Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
Intraday
Monitor top intraday performers in real time
ETF Screener
Get the best of Mutual Funds and flexibility of Stocks
IPO
Track upcoming and ongoing IPOs
MTFs
Buy now, pay later
Stock Screener
Filter based on RSI, PE ratio and more
Stock Events
Dividends, bonus, buybacks and more
Demat Account
Begin your stock market journey
Share Market Today
Live news updates from stock market
F&O
Trade in Futures & Options
Trade in F&O using the terminal. View charts, indicators, track your orders , P&L and watchlists in a single space
Indices
Track markets across the globe
Terminal
Track charts, orders, positions, watchlists in one place
Option chain
Analyse chains, view payoffs, create baskets
Pledge
Get extra balance for trading
Commodities
Trade in Crude Oil, Gold, Silver and more
API trading
Set up and execute trades through our API
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
Mutual Fund Houses
Know about AMCs, funds, fund managers
NFO’s
Track all active NFOs in one place
Mutual Funds by Groww
Mutual funds by Groww designed for your investment goals
Start SIP
Build long-term wealth through disciplined monthly investing.
Mutual Funds screener
Filter funds based on risk, fund size and more
Track Funds
Import funds and track all investments in a single place
Compare Funds
More
SIP calculator
Estimate returns on a SIP
Brokerage calculator
Estimate charges for your trade/investment
Margin calculator
Estimate balance needed to buy/sell a stock
SWP calculator
Returns on your systematic withdrawal plan
Pricing
Brokerage and charges on Groww
Blog
Manage alerts
Active alerts for Orchid Pharma
Add new alert
ORCHPHARMA •
NSE
Orchid Pharma
₹625.75
12.90 (2.10%)
1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Terminal
Create Stock SIP
Automate your investments in this
Overview
Technicals
News
Events
BSE •
3 weeks ago
NCLT Chennai dismissed DBS Bank's application against Orchid Pharma regarding lease rent claims during CIRP. Order dated April 2, 2026, had no financial or operational impact on Orchid Pharma's activities.
BSE •
4 weeks ago
Orchid Pharma's credit rating was downgraded by CARE Ratings from CARE A- to CARE BBB- with a stable outlook. Short-term ratings were reaffirmed at CARE A2, removing ratings from watch with developing implications.
ScoutQuest •
1 month ago
NCLT reserves merger order for Dhanuka Labs' amalgamation into Orchid Pharma. Formal order expected soon; updates to be shared on company website and exchanges.
ScoutQuest •
3 months ago
Orchid Pharma focuses on FY26 transition with new product launches. Company plans Rs.450 crore 7ACA project for asset expansion.
Livesquawk •
3 months ago
Orchid Pharma posted a Q3 net loss of ₹126M vs ₹208M profit YoY. Q3 revenue declined to ₹2.07B from ₹2.2B YoY.
BSE •
3 months ago
Orchid Pharma's Board Meeting on Feb 11, 2026, will review Q3 FY 2025-26 financial results. Trading window closure remains until 48 hours after results declaration, effective Jan 1, 2026.
Marketsmojo •
4 months ago
Orchid Pharma faces revised evaluation metrics due to operational challenges. Key issues include quality valuation, financial trends, and technical outlook.